These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37605251)

  • 21. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
    Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
    Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J; Li HL; Zhai B; Chang S; Li FH
    Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus?
    Giorgio A; Di Sarno A; de Stefano G; Farella N; Scognamiglio U; de Stefano M; Giorgio V
    AJR Am J Roentgenol; 2009 Oct; 193(4):948-54. PubMed ID: 19770315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound.
    Ju JX; Zeng QJ; Xu EJ; He XQ; Tan L; Huang QN; Li K; Zheng RQ
    Int J Hyperthermia; 2019; 36(1):785-793. PubMed ID: 31431086
    [No Abstract]   [Full Text] [Related]  

  • 25. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy.
    Chen J; Lin Z; Lin Q; Lin R; Yan Y; Chen J
    Int J Hyperthermia; 2020; 37(1):192-201. PubMed ID: 32066293
    [No Abstract]   [Full Text] [Related]  

  • 26. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation.
    Xu HX; Xie XY; Lu MD; Chen JW; Yin XY; Xu ZF; Liu GJ
    Clin Radiol; 2004 Jan; 59(1):53-61. PubMed ID: 14697375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
    Rhim H; Choi D; Kim YS; Lim HK; Choe BK
    Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-enhanced ultrasound-guided feeding artery ablation as add-on to percutaneous radiofrequency ablation for hypervascular hepatocellular carcinoma with a modified ablative technique and tumor perfusion evaluation.
    Li X; Xu M; Liu M; Tan Y; Zhuang B; Lin M; Kuang M; Xie X
    Int J Hyperthermia; 2020; 37(1):1016-1026. PubMed ID: 32865050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
    Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
    J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence.
    Kobe A; Kindler Y; Klotz E; Puippe G; Messmer F; Alkadhi H; Pfammatter T
    Invest Radiol; 2021 Mar; 56(3):188-196. PubMed ID: 32932379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
    Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
    Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
    Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW
    Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy.
    Hermida M; Cassinotto C; Piron L; Assenat E; Pageaux GP; Escal L; Pierredon-Foulongne MA; Verzilli D; Jaber S; Guiu B
    Int J Hyperthermia; 2018 Dec; 35(1):90-96. PubMed ID: 29923441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
    Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
    Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance.
    Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK
    Korean J Radiol; 2012; 13(6):784-94. PubMed ID: 23118578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility.
    Kim PN; Choi D; Rhim H; Rha SE; Hong HP; Lee J; Choi JI; Kim JW; Seo JW; Lee EJ; Lim HK
    J Vasc Interv Radiol; 2012 May; 23(5):627-34. PubMed ID: 22387030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mistargeting after fusion imaging-guided percutaneous radiofrequency ablation of hepatocellular carcinomas.
    Lim S; Lee MW; Rhim H; Cha DI; Kang TW; Min JH; Song KD; Choi SY; Lim HK
    J Vasc Interv Radiol; 2014 Feb; 25(2):307-14. PubMed ID: 24315550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy.
    Kim SW; Rhim H; Park M; Kim H; Kim YS; Choi D; Lim HK
    Korean J Radiol; 2009; 10(4):366-76. PubMed ID: 19568465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.